Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association

Stroke. 2011 Jan;42(1):227-76. doi: 10.1161/STR.0b013e3181f7d043. Epub 2010 Oct 21.

Abstract

The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or transient ischemic attack. Evidence-based recommendations are included for the control of risk factors, interventional approaches for atherosclerotic disease, antithrombotic treatments for cardioembolism, and the use of antiplatelet agents for noncardioembolic stroke. Further recommendations are provided for the prevention of recurrent stroke in a variety of other specific circumstances, including arterial dissections; patent foramen ovale; hyperhomocysteinemia; hypercoagulable states; sickle cell disease; cerebral venous sinus thrombosis; stroke among women, particularly with regard to pregnancy and the use of postmenopausal hormones; the use of anticoagulation after cerebral hemorrhage; and special approaches to the implementation of guidelines and their use in high-risk populations.

Publication types

  • Practice Guideline

MeSH terms

  • Anemia, Sickle Cell / complications
  • Anemia, Sickle Cell / therapy
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Atherosclerosis / complications
  • Atherosclerosis / therapy
  • Cerebral Hemorrhage / complications
  • Cerebral Hemorrhage / therapy
  • Embolism / complications
  • Embolism / therapy
  • Evidence-Based Medicine
  • Female
  • Foramen Ovale, Patent / complications
  • Foramen Ovale, Patent / therapy
  • Heart Diseases / complications
  • Heart Diseases / therapy
  • Humans
  • Hyperhomocysteinemia / complications
  • Hyperhomocysteinemia / therapy
  • Ischemic Attack, Transient / complications*
  • Ischemic Attack, Transient / therapy
  • Male
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / therapy
  • Recurrence
  • Risk Factors
  • Stroke / etiology*
  • Stroke / prevention & control*
  • Thrombophilia / complications
  • Thrombophilia / therapy
  • Thrombosis / complications
  • Thrombosis / therapy

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors